References
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th. text rev. 2022. doi: 10.1176/appi.books.9780890425787
- Schulte EM, Grilo CM, Gearhardt AN. Shared and unique mechanisms underlying binge eating disorder and addictive disorders. Clin Psychol Rev. 2016 Mar;44:125–139. doi: 10.1016/j.cpr.2016.02.001
- Paul A, Ghanta A, Chao AM. Features of addiction in binge-eating disorder: considerations for screening and treatment. 2023 Published 2023 Aug 4;14:77–87. doi: 10.2147/SAR.S391636
- Frank GKW, Shott ME, DeGuzman MC. The neurobiology of eating disorders. Child Adolesc Psychiatr Clin N. Am. 2019 Oct;28(4):629–640. doi: 10.1016/j.chc.2019.05.007
- Hunt TK, Forbush KT. Is “drunkorexia” an eating disorder, substance use disorder, or both? Eat Behav. 2016 Aug;22:40–45. doi: 10.1016/j.eatbeh.2016.03.034
- European Monitoring Centre for Drugs and Drug Addiction (2023). European drug report 2023: trends and developments. [cited Jul 12, 2023] https://www.emcdda.europa.eu/publications/european-drug-report/2023_en
- Schifano F, Napoletano F, Chiappini S, et al. New/Emerging psychoactive substances and associated psychopathological consequences. Psychol Med. 2021 Jan;51(1):30–42. doi: 10.1017/S0033291719001727
- De Berardis D, Matarazzo I, Orsolini L, et al. The problem of eating disorders and comorbid psychostimulants abuse: a mini review. Neuropsychiatry. 2019;9(3):2359–2368
- Schifano F, Chiappini S, Corkery JM, et al. Abuse of prescription drugs in the context of Novel Psychoactive substances (NPS): a systematic review. Brain Sci. 2018 Apr 22;8(4):73. doi: 10.3390/brainsci8040073
- Levine DA. ‘Pharming’: the abuse of prescription and over-the-counter drugs in teens. Curr Opin Paediatr. 2007;19(3):270–274. doi: 10.1097/MOP.0b013e32814b09cf
- Reeves RR, Ladner ME, Perry CL, et al. Abuse of medications that theoretically are without abuse potential. South Med J. 2015 Mar;108(3):151–157. doi: 10.14423/SMJ.0000000000000256
- Bruening AB, Perez M, Ohrt TK. Exploring weight control as motivation for illicit stimulant use. Eat Behav. 2018 Aug;30:72–75. doi: 10.1016/j.eatbeh.2018.06.002
- Jeffers AJ, Benotsch EG. Non-medical use of prescription stimulants for weight loss, disordered eating, and body image. Eat Behav. 2014 Aug;15(3):414–418. doi: 10.1016/j.eatbeh.2014.04.019
- van de Ven K, Koenraadt R. Exploring the relationship between online buyers and sellers of image and performance enhancing drugs (IPEDs): quality issues, trust and self-regulation. Int J Drug Policy. 2017 Dec;50:48–55. doi: 10.1016/j.drugpo.2017.09.004
- Valdesolo F What you need to know about ozempic: the diabetes drug fuelling Hollywood’s harmful weight-loss obsession. 10 Feb 2023. [cited Jul 12, 2022]. https://www.vogue.co.uk/beauty/article/what-is-ozempic
- Richards J, Bang N, Ratliff EL, et al. Successful treatment of binge eating disorder with the GLP-1 agonist semaglutide: a retrospective cohort study. Obesity Pillars. 2023 Sep;100080. doi: 10.1016/j.obpill.2023.100080
- ANSM (2023). Ozempic (sémaglutide) : un médicament à utiliser uniquement dans le traitement du diabète de type 2 [cited Jul 12, 2023. https://ansm.sante.fr/actualites/ozempic-semaglutide-un-medicament-a-utiliser-uniquement-dans-le-traitement-du-diabete-de-type-2
- Le Monde, 2023. [cited Jul 12, 2023]. https://www.lemonde.fr/en/health/article/2023/03/02/ozempic-french-authorities-issue-alert-for-anti-diabetic-drug-misused-for-weight-loss_6017913_14.html#:~:text=While%20misuse%20of%20Ozempic%20appears,them%20of%20this%20essential%20treatment.%22
- Chiappini S, Vickers-Smith R, Harris D, et al. Is there a risk for semaglutide misuse? Focus on the food and drug Administration’s FDA adverse events Reporting system (FAERS) pharmacovigilance dataset. Pharmaceuticals. 2023;16(7):994. doi: 10.3390/ph16070994
- Holborn T, Schifano F, Deluca P. No prescription? No problem: a qualitative study investigating self-medication with novel psychoactive substances (NPS). Int J Drug Policy. 2023 Jul 7;118:104109.10.1016/j.drugpo.2023.104109
- Orsolini L, Francesconi G, Papanti D, et al. Profiling online recreational/prescription drugs’ customers and overview of drug vending virtual marketplaces. Hum Psychopharmacol. 2015 Jul;30(4):302–318. doi: 10.1002/hup.2466
- Zaprutko T, Kopciuch D, Paczkowska A, et al. Facebook as a source of access to medicines. PLoS One. 2022 Oct 13;17(10):e0275272. doi: 10.1371/journal.pone.0275272